Suchergebnisse - "Clinical trial"

PubPharm (717.832)

1

Use of pragmatic randomized trials in multiple sclerosis : A systematic overview

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2024

von Hirt, J. | Janiaud, P. | Düblin, P. | +10

2

Doubly adaptive biased coin design to improve Bayesian clinical trials with time-to-event endpoints

enthalten in: Statistics in medicine | 2024

von Cao, W. | Zhu, H. | Wang, L. | +2

3

Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab efficacy in patients with head and neck squamous cell carcinoma : Post hoc analysis of TRIUMPH study

enthalten in: Oral oncology | 2024

von Kim, D. | Lim, S. | Kim, H. | +12

4

Dolutegravir/Lamivudine Is Noninferior to Continuing Dolutegravir- and Non-Dolutegravir-Based Triple-Drug Antiretroviral Therapy in Virologically Suppressed People With Human Immunodeficiency Virus : DUALING Prospective Nationwide Matched Cohort Study

enthalten in: Open forum infectious diseases | 2024

von Vasylyev, M. | Wit, F. | Jordans, C. | +23

5

Immunogenicity and safety of SARS-CoV-2 recombinant protein subunit vaccine (IndoVac) adjuvanted with alum and CpG 1018 in Indonesian adults : A phase 3, randomized, active-controlled, multicenter trial

enthalten in: Vaccine | 2024

von Nurdin, A. | Movieta Nency, Y. | Maddeppungeng, M. | +24

6

Immunogenicity and safety of adsorbed diphtheria-purified pertussis-tetanus-inactivated polio (Sabin strain)-Haemophilus type b conjugate combined vaccine (DPT-IPV-Hib) in healthy Japanese Infants ≥ 2 and < 43 months of Age : A phase III, multicenter, active controlled, assessor-blinded, randomized, parallel-group study

enthalten in: Vaccine | 2024

von Nakano, T. | Hasegawa, M. | Endo, M. | +2

7

A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S formulated with AS02 adjuvant in healthy, malaria-naïve adults

enthalten in: Vaccine | 2024

von Cummings, J. | Polhemus, M. | Kester, K. | +13

8

Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma : a phase 1/2 trial

enthalten in: Nature medicine | 2024

von Yarchoan, M. | Gane, E. | Marron, T. | +17

9

Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations : Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E

enthalten in: JCO precision oncology | 2024

von Chen, M. | Song, Z. | Yu, H. | +19

10

Impact of the number of modifiable risk factors on clinical outcomes after percutaneous coronary intervention : An analysis from the e-Ultimaster registry

enthalten in: International journal of cardiology. Heart & vasculature | 2024

von Kobo, O. | Levi, Y. | Abu-Fanne, R. | +11

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[71784]